A Search for the Protonation Model with Thermodynamic Dissociation Constants and (Extra)-Thermodynamics of Nilotinib Hydrochloride (TASIGNA)

Meloun, Milan; Pilařová, Lucie; Javůrek, Milan; Pekárek, Tomáš

doi:10.1007/s10953-019-00882-2

Cited by 1 publication

(1 citation statement)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The presence of tertiary amine in the pyridine moiety of the NIL structure could deduce this ratio. [ 25 ] In a weakly acidic medium, NIL positively charged nitrogen atom of two molecules could react with the two negatively charged ionized hydroxyl groups of EB. Consequently, as presented in Scheme 1, electrostatic interaction resulted in the formation of an ion‐pairing complex between NIL and EB.…”

Section: Resultsmentioning

confidence: 99%

Utility of a xanthene‐based dye for determination of nilotinib using two spectroscopic approaches. Applications to bulk powder, capsules, and spiked human plasma

et al. 2023

View full text Add to dashboard Cite

Novel, selective, facile, and precise spectroscopic approaches were validated to determine nilotinib hydrochloride, a tyrosine kinase inhibitor used to treat patients with chronic myeloid leukemia. These approaches depend on the reaction of the tertiary amine group of nilotinib with erythrosine B in the Britton-Robinson buffer at pH 4.Method I, depends on measuring the absorbance of the formed complex at 551 nm.The absorbance concentration plot showed linearity over the concentration range of 1.0 to 9.0 μg/ml. Method II, involved the measurement of the quenching of the native fluorescence of erythrosine B by adding nilotinib in an acidic medium. The fluorescence quenching of erythrosine B was measured at 549 nm after excitation at 528 nm. This approach showed excellent linearity in the concentration range of 0.04 to 0.7 μg/ml. The limit of detection values for Method I and Method II were 0.225 and 0.008 μg/ml, respectively, while the limit of quantitation values for Method I and Method II were 0.68 and 0.026 μg/ml, respectively. To get the optimal conditions, factors that may affect the formation of the ion-pairing complex were thoroughly examined. The two approaches were carefully validated following the International Conference of Harmonization (ICH Q2R1) guidelines. Statistical assessment of the results achieved using the suggested and previously published comparison approaches showed no significant difference. The approaches were successful in determining nilotinib in a pharmaceutical dosage form as well as spiked human plasma samples. The eco-friendly properties of the methods were evaluated by three different tools.

show abstract

Section: Resultsmentioning

confidence: 99%